Randomized Trial of Early Hemodynamic Management of Patients Following Acute Spinal Cord Injury
TEMPLE
2 other identifiers
interventional
94
1 country
11
Brief Summary
The purpose of this study is to learn more about how participants heal from acute spinal cord injury.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2017
Longer than P75 for not_applicable
11 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 3, 2016
CompletedFirst Posted
Study publicly available on registry
August 25, 2016
CompletedStudy Start
First participant enrolled
May 22, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 26, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
July 26, 2023
CompletedResults Posted
Study results publicly available
November 24, 2025
CompletedJanuary 21, 2026
October 1, 2025
6.2 years
August 3, 2016
August 4, 2025
January 2, 2026
Conditions
Outcome Measures
Primary Outcomes (3)
Change From Baseline in American Spinal Injury (ASIA) Upper Extremities Motor Score
Change from baseline in ASIA Upper Extremities Motor Score (UEMS), comparing patients maintained at a MAP target between 65 and 70 mm Hg, and patients maintained at a MAP target between 85 and 90 mm Hg for a duration of seven days or until ICU discharge. The UEMS score ranges from 0 to 50, with 50 indicating no deficits.
6 months after spinal cord injury
Change From Baseline in American Spinal Injury (ASIA) Lower Extremities Motor Score
Change from baseline in ASIA Lower Extremities Motor Score (LEMS), comparing patients maintained at a MAP target between 65 and 70 mm Hg, and patients maintained at a MAP target between 85 and 90 mm Hg for a duration of seven days or until ICU discharge. The LEMS score ranges from 0 to 50, with 50 indicating no deficits.
6 months after spinal cord injury
Change From Baseline in American Spinal Injury Association (ASIA) Sensory Score
Change from baseline in ASIA Sensory Score, comparing patients maintained at a MAP target between 65 and 70 mm Hg, and patients maintained at a MAP target between 85 and 90 mm Hg for a duration of seven days or until ICU discharge. The total Sensory Score adds light touch points (max 112) and pin prick points (max 112). The total score ranges from 0 to 224, with higher scores indicating better neurological outcomes.
6 months after spinal cord injury
Secondary Outcomes (3)
Spinal Cord Independence Measure III Score
6 months after spinal cord injury
Pain Scores on the International Spinal Cord Injury Basic Pain Data Set
6 months after spinal cord injury
International Spinal Cord Injury Quality of Life (ISCIQoL) Basic Data Set
6 months after spinal cord injury
Other Outcomes (3)
Incidence of Respiratory Complications
7 days after randomization or ICU discharge, whichever came first, assessed up to 7 days
Cardiovascular Function
6 months after spinal cord injury
Sequential Multiple Organ Assessment (SOFA) Score
7 days after randomization
Study Arms (2)
Augmented Blood Pressure
EXPERIMENTALSubjects will have their blood pressure kept in a higher range.
Conventional Blood Pressure
NO INTERVENTIONSubjects will have their blood pressure kept in a normal range.
Interventions
Subjects will have their blood pressure kept in a higher range.
Eligibility Criteria
You may qualify if:
- Acute traumatic spinal cord injury (SCI) involving neurological levels as defined by the ASIA neurological examination between C0 and T8 (tetraplegia) and resulting in new onset neurological deficits consistent with an ASIA motor assessment of level A, B or C.
- Subject is 18 years of age or older.
You may not qualify if:
- Penetrating SCI injury.
- Isolated cauda equina syndrome or injury at bony level Th9 or below.
- Pre-existing motor deficit secondary to chronic myelopathy.
- History of demyelinating disease or central nervous system autoimmune disorder.
- History within the past six months and/or physical findings on admission of decompensated congestive heart failure (NYHA functional class III or IV, or objective class C or D).
- Acute, evolving or recent (30 days) myocardial infarction.
- Chronic renal failure requiring dialysis.
- Suspected or confirmed pregnancy.
- Severe terminal disease with life expectancy less than 6 months.
- Severe traumatic brain injury at presentation (GCS ≤8) with confirmation of injury on brain imaging.
- A condition that would preclude the performance of an accurate neurological exam due to a prior diagnosis of Alzheimer's disease, stroke, degenerative condition, cerebral tumor, or mental retardation.
- Non-English or Non-Spanish Speaking.
- Refusal of consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (11)
University of Southern California
Los Angeles, California, 90033, United States
Yale University
New Haven, Connecticut, 06511, United States
University of Kansas Medical Center
Kansas City, Kansas, 66160, United States
University of Maryland Medical Center
Baltimore, Maryland, 21201, United States
Atrium Health F.H. Sammy Ross Trauma Center
Charlotte, North Carolina, 28203, United States
Atrium Health Wake Forest Baptist
Winston-Salem, North Carolina, 27157, United States
University of Cincinnati Medical Center
Cincinnati, Ohio, 45267, United States
Oregon Health & Science University
Portland, Oregon, 97239, United States
University of Pennsylvania Health System
Philadelphia, Pennsylvania, 19104, United States
Thomas Jefferson University
Philadelphia, Pennsylvania, 19107, United States
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, 15213, United States
Related Publications (2)
Sajdeya R, Yanez ND, Kampp M, Goodman MD, Zonies D, Togioka B, Nunn A, Winfield RD, Martin ND, Kohli A, Huynh TT, Okonkwo DO, Poblete RA, Gilmore EJ, Chesnut RM, Bunnell AE, Ohnuma T, Hashemaghaie M, Treggiari MM. Early Blood Pressure Targets in Acute Spinal Cord Injury: A Randomized Clinical Trial. JAMA Netw Open. 2025 Sep 2;8(9):e2525364. doi: 10.1001/jamanetworkopen.2025.25364.
PMID: 40965887DERIVEDWeinberg JA, Farber SH, Kalamchi LD, Brigeman ST, Bohl MA, Varda BM, Sioda NA, Radosevich JJ, Chapple KM, Snyder LA. Mean arterial pressure maintenance following spinal cord injury: Does meeting the target matter? J Trauma Acute Care Surg. 2021 Jan 1;90(1):97-106. doi: 10.1097/TA.0000000000002953.
PMID: 33003016DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Miriam Treggiari
- Organization
- Duke University
Study Officials
- PRINCIPAL INVESTIGATOR
Miriam Treggiari, MD, PhD, MPH
Oregon Health and Science University
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
August 3, 2016
First Posted
August 25, 2016
Study Start
May 22, 2017
Primary Completion
July 26, 2023
Study Completion
July 26, 2023
Last Updated
January 21, 2026
Results First Posted
November 24, 2025
Record last verified: 2025-10
Data Sharing
- IPD Sharing
- Will not share